Classifying drug interactions.
作者信息
Aronson J K
出版信息
Br J Clin Pharmacol. 2004 Oct;58(4):343-4. doi: 10.1111/j.1365-2125.2004.02244.x.
Abstract
摘要
相似文献
1
Classifying drug interactions.
Br J Clin Pharmacol. 2004 Oct;58(4):343-4. doi: 10.1111/j.1365-2125.2004.02244.x.
2
Induction and inhibition of CYPs and implications for medicine.
Mol Aspects Med. 1999 Feb-Apr;20(1-2):24-33, 34-137.
3
[Drug interactions with the cytochrome P-450 system].
Dtsch Med Wochenschr. 2000 Jan 21;125(3):63-7. doi: 10.1055/s-2007-1023908.
4
Drug-drug interactions with immunosuppressive agents: review of the in vitro functional assays and role of cytochrome P450 enzymes.
Transplantation. 2008 May 15;85(9):1222-9. doi: 10.1097/TP.0b013e31816fc03b.
5
Cytochrome P450 and its role in veterinary drug interactions.
Vet Clin North Am Small Anim Pract. 2006 Sep;36(5):975-85, v. doi: 10.1016/j.cvsm.2006.05.003.
6
[Cytochromes P-450, drug disease, and personified medicine. Part I].
Klin Med (Mosk). 2008;86(2):4-8.
7
Cholesterol reduction, statins and the cytochrome P-450 system.
Eur Heart J. 2000 Sep;21(18):1555-6. doi: 10.1053/euhj.2000.2073.
8
The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
Am Fam Physician. 2007 Aug 1;76(3):391-6.
9
In vitro cytochrome P450 inhibition data and the prediction of drug-drug interactions: qualitative relationships, quantitative predictions, and the rank-order approach.
Clin Pharmacol Ther. 2005 Dec;78(6):582-92. doi: 10.1016/j.clpt.2005.09.004.
10
Antiretroviral and statin drug-drug interactions.
Cardiol Rev. 2009 Jan-Feb;17(1):44-7. doi: 10.1097/CRD.0b013e3181903b7f.
引用本文的文献
1
Molecular Precision Medicine: Application of Physiologically Based Pharmacokinetic Modeling to Predict Drug-Drug Interactions Between Lidocaine and Rocuronium/Propofol/Paracetamol.
Int J Mol Sci. 2025 Feb 11;26(4):1506. doi: 10.3390/ijms26041506.
2
Discovering Severe Adverse Reactions From Pharmacokinetic Drug-Drug Interactions Through Literature Analysis and Electronic Health Record Verification.
Clin Pharmacol Ther. 2025 Apr;117(4):1078-1087. doi: 10.1002/cpt.3500. Epub 2024 Nov 25.
3
Survey of Potential Drug Interactions, Use of Non-Medical Health Products, and Immunization Status among Patients Receiving Targeted Therapies.
Pharmaceuticals (Basel). 2024 Jul 14;17(7):942. doi: 10.3390/ph17070942.
4
Effect of on the pharmacokinetic profile of tofacitinib and the underlying mechanism.
Front Pharmacol. 2024 Apr 8;15:1351882. doi: 10.3389/fphar.2024.1351882. eCollection 2024.
5
A Review of the Lidocaine in the Perioperative Period.
J Pers Med. 2023 Dec 11;13(12):1699. doi: 10.3390/jpm13121699.
6
Antibiotics and Lipid-Modifying Agents: Potential Drug-Drug Interactions and Their Clinical Implications.
Pharmacy (Basel). 2023 Aug 19;11(4):130. doi: 10.3390/pharmacy11040130.
7
New Perspective for Drug-Drug Interaction in Perioperative Period.
J Clin Med. 2023 Jul 21;12(14):4810. doi: 10.3390/jcm12144810.
8
Drug-Drug Interactions among Patients Hospitalized with COVID-19 in Greece.
J Clin Med. 2022 Dec 2;11(23):7172. doi: 10.3390/jcm11237172.
9
Drug Interactions between Antimicrobial and Immunosuppressive Agents in Solid Organ Transplant Recipients.
Indian J Crit Care Med. 2021 Jan;25(1):67-76. doi: 10.5005/jp-journals-10071-23439.
10
Prevalence and Clinical Significance of Drug-Drug and Drug-Dietary Supplement Interactions among Patients Admitted for Cardiothoracic Surgery in Greece.
Pharmaceutics. 2021 Feb 9;13(2):239. doi: 10.3390/pharmaceutics13020239.
本文引用的文献
1
Drug interactions-information, education, and the British National Formulary.
Br J Clin Pharmacol. 2004 Apr;57(4):371-2. doi: 10.1111/j.1365-2125.2004.02125.x.
2
The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humans.
Clin Pharmacol Ther. 1996 Sep;60(3):295-307. doi: 10.1016/S0009-9236(96)90056-9.
3
British National Formulary: its birth, death, and rebirth.
BMJ. 1993 Apr 17;306(6884):1051-4. doi: 10.1136/bmj.306.6884.1051.
4
Oral contraceptive steroids--pharmacological issues of interest to the prescribing physician.
Adv Contracept. 1991 Dec;7(4):325-31. doi: 10.1007/BF02340178.
Zotero 插件